John W. Childs, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 47,400 shares at $60.32 ($2.9M) on 2020-08-11, disclosed to the SEC on 2020-08-12.
Open-market purchase of $2.9M BHVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.32 | 2,600 | $157K | 5.4% |
| 2 | $61.28 | 7,271 | $446K | 15.3% |
| 3 | $61.28 | 7,271 | $446K | 15.3% |
| 4 | $61.87 | 15,129 | $936K | 32.1% |
| 5 | $61.87 | 15,129 | $936K | 32.1% |
| Total | $61.60 avg | 47,400 |
| $2.9M |
| 100% |
| Filing → |
| MANE | BUY | 2026-02-05 | $5.0M | — | Filing → |
| BHVN | BUY | 2025-11-17 | $50.0M | — | Filing → |
| BHVN | BUY | 2025-03-05 | $892K | — | Filing → |